5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Fecal Incontinence in Inflammatory Bowel Disease

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Fecal incontinence (FI) is frequently reported in inflammatory bowel disease (IBD).

          Methods

          We retrospectively reviewed data from the Study of a Prospective Adult Research Cohort with IBD registry.

          Results

          Three hundred forty-seven patients had Crohn disease and 145 had ulcerative colitis. 14.2% of patients reported FI. FI was associated with active disease. FI was not associated with disease location, phenotype, or perianal involvement. Greater than 50 years of age or 15 years of disease increased the odds of FI and remission decreased the odds of FI.

          Conclusions

          Further research into the mechanism of FI in IBD is needed.

          Lay Summary

          Patients with Crohn disease and ulcerative colitis are equally affected by fecal incontinence. The factors that increase a patient’s risk include symptomatic disease, increased disease duration, and age >50 years-old. Gender, disease location, and medications did not increase the risk.

          Related collections

          Most cited references22

          • Record: found
          • Abstract: found
          • Article: not found

          Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study.

          Needing a single index of degree of illness in Crohn's disease, the National Cooperative Crohn's Disease Study group collected data prospectively from 187 visits of 112 patients with Crohn's disease of the small bowel, colon, or both. Information on 18 predictor variables was gathered at each visit. In addition, the attending physician rated his over-all evaluation of how well the patient was doing and compared the patient's status with that at the previous visit. A multiple regression computer program was utilized to derive an equation for prediction of the physician's over-all ratings from a subset of the predictor variables fulfilling a combination of constraints. This equation, numerically simplified and utilizing eight selected variables, is the Crohn's Disease Activity Index. Index values of 150 and below are associated with quiescent disease; values above that indicate active disease, and values above 450 are seen with extremely severe disease.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Risk of surgery for inflammatory bowel diseases has decreased over time: a systematic review and meta-analysis of population-based studies.

            The inflammatory bowel diseases (IBDs) are chronic diseases that often require surgery. However, the risk of requirement of surgery over time has not been well characterized. We performed a systematic review and meta-analysis to establish the cumulative risk of surgery among patients with IBD and evaluated how this risk has changed over time.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis.

              The efficacy and safety of 4-g 5-aminosalicylic acid enemas were assessed in 153 patients with ulcerative colitis involving up to 50 cm of distal colon. Seventy-six patients received active medication and 77 received a placebo. There were 20 dropouts (6 in the active group and 14 in the placebo group) during the study because of insufficient efficacy. After 6 wk of therapy, 48 of the 76 patients (63%) receiving 5-aminosalicylic acid were considered to be "much improved" by the study physician compared to 22 of the 77 patients (29%) on placebo (p = 0.001). A disease activity index based on patient symptoms and sigmoidoscopic appearance was used to assess efficacy. Mean disease activity index declined 55% for patients on 5-aminosalicylic acid and 24% for patients on placebo (p = 0.0001). Analysis of subgroups indicated that patients most likely to respond were those with disease confined to the 20-40 cm from the anus. Response was not affected by concurrent sulfasalazine, but patients requiring concurrent oral steroids had a diminished response. Rapid onset of efficacy was shown by a significant reduction in rectal bleeding within 3 days of treatment initiation. 5-Aminosalicylic acid enemas are well tolerated and are of benefit in the treatment of ulcerative colitis confined to the distal colon.
                Bookmark

                Author and article information

                Journal
                Crohns Colitis 360
                Crohns Colitis 360
                crohnscolitis360
                Crohn's & Colitis 360
                Oxford University Press (US )
                2631-827X
                April 2021
                24 February 2021
                24 February 2021
                : 3
                : 2
                : otab013
                Affiliations
                University of Maryland School of Medicine , Baltimore, Maryland, USA
                Author notes
                Address correspondence to: Raymond K. Cross, MD, MS, 685 W. Baltimore Street, Suite 8-00, Baltimore, MD 21201, USA ( rcross@ 123456som.umaryland.edu ).
                Author information
                https://orcid.org/0000-0001-9766-5196
                Article
                otab013
                10.1093/crocol/otab013
                8248884
                34226891
                e81adf3a-8b30-4996-a182-cfd7fe685393
                © The Author(s) 2021. Published by Oxford University Press on behalf of Crohn's & Colitis Foundation.

                This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com

                History
                : 28 September 2020
                : 06 December 2020
                : 13 April 2021
                Page count
                Pages: 8
                Funding
                Funded by: National Institutes of Health, DOI 10.13039/100000002;
                Funded by: National Institute of Diabetes and Digestive and Kidney Diseases, DOI 10.13039/100000062;
                Award ID: T32 DK067872
                Categories
                Observations and Research
                AcademicSubjects/MED00260
                AcademicSubjects/MED00760
                AcademicSubjects/MED00972

                quality of life,diarrhea,crohn disease,ulcerative colitis,incontinence

                Comments

                Comment on this article